Darnell RB - Search Results

1

Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation.

Longman RS, Braun D, Pellegrini S, Rice CM, Darnell RB, Albert ML. Longman RS, et al. Among authors: darnell rb. Blood. 2007 Feb 1;109(3):1113-22. doi: 10.1182/blood-2006-05-023465. Epub 2006 Oct 3. Blood. 2007. PMID: 17018853 Free article.

2

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Albert ML, et al. Among authors: darnell jc, darnell rb. Nat Med. 1998 Nov;4(11):1321-4. doi: 10.1038/3315. Nat Med. 1998. PMID: 9809559

3

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.

Albert ML, Austin LM, Darnell RB. Albert ML, et al. Among authors: darnell rb. Ann Neurol. 2000 Jan;47(1):9-17. Ann Neurol. 2000. PMID: 10632096

4

Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.

Darnell JC, Albert ML, Darnell RB. Darnell JC, et al. Among authors: darnell rb. Cancer Res. 2000 Apr 15;60(8):2136-9. Cancer Res. 2000. PMID: 10786675

5

cdr2-specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed.

Darnell RB, Albert ML. Darnell RB, et al. Ann Neurol. 2000 Aug;48(2):270-1. Ann Neurol. 2000. PMID: 10939585 No abstract available.

6

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.

Albert ML, Jegathesan M, Darnell RB. Albert ML, et al. Among authors: darnell rb. Nat Immunol. 2001 Nov;2(11):1010-7. doi: 10.1038/ni722. Nat Immunol. 2001. PMID: 11590405

7

Paraneoplastic neurological degenerations: keys to tumour immunity.

Albert ML, Darnell RB. Albert ML, et al. Among authors: darnell rb. Nat Rev Cancer. 2004 Jan;4(1):36-44. doi: 10.1038/nrc1255. Nat Rev Cancer. 2004. PMID: 14708025 Review. No abstract available.

8

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy.

Orange DE, Jegathesan M, Blachère NE, Frank MO, Scher HI, Albert ML, Darnell RB. Orange DE, et al. Among authors: darnell rb. Prostate Cancer Prostatic Dis. 2004;7(1):63-72. doi: 10.1038/sj.pcan.4500694. Prostate Cancer Prostatic Dis. 2004. PMID: 14999241

9

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation.

Blachère NE, Darnell RB, Albert ML. Blachère NE, et al. Among authors: darnell rb. PLoS Biol. 2005 Jun;3(6):e185. doi: 10.1371/journal.pbio.0030185. Epub 2005 Apr 26. PLoS Biol. 2005. PMID: 15839733 Free PMC article.

10

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.

Blachère NE, Morris HK, Braun D, Saklani H, Di Santo JP, Darnell RB, Albert ML. Blachère NE, et al. Among authors: darnell rb. J Immunol. 2006 Jun 15;176(12):7288-300. doi: 10.4049/jimmunol.176.12.7288. J Immunol. 2006. PMID: 16751372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters